Today on DrugResearcher.com
 
Astellas snaps up cancer antibody specialists Agensys

ERC to provide 4bn Euros for 'far-reaching research'

Nano-flares light the way for in-cell mRNA detection

Xenome and Amylin team up to poison metabolic diseases

Private equity firm puts crores into Indian CRO

 
   
Related Industry News
 
AstraZeneca finds buyer for German plant

PolyTherics gets funding for antibody fragments

Contract manufacturing news in brief

Chromatide wins GRAND grant for enzyme-catalysis development

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Tuesday 27 November 2007 Forward to a colleague

Sponsored Link

Fully autoclavable and Universal tip fittingCappAero pipettes - ultimate accuracy and intelligent design

The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here

Access Full Stories



Astellas snaps up cancer antibody specialists Agensys
Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer... Read


ERC to provide 4bn Euros for 'far-reaching research'
The European Research Council (ERC) has announced it will fund Europe's very best research projects to the tune of €4bn in a bid to improve Europe's position at the frontiers of research... Read


Nano-flares light the way for in-cell mRNA detection
Researchers have developed a nanoparticle signalling system that can be used as cellular 'nano-flares' that enable the visualisation and quantification of RNA in living cells... Read


Xenome and Amylin team up to poison metabolic diseases
Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read


Private equity firm puts crores into Indian CRO
GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read


All News Headlines for:
November | October | September

Related Industry News



AstraZeneca finds buyer for German plant
Reports emerged in the German press yesterday claiming that AstraZeneca has found a buyer for its Plankstadt manufacturing facility... Read


PolyTherics gets funding for antibody fragments
PolyTherics has been boosted with £350,000 ($723,135) in funding to explore the development and production of long-lasting therapeutic antibody fragments... Read


Contract manufacturing news in brief
Dr Reddy's, China Aoxing Pharmaceutical, Cook Pharmica and Alpha Biologics have all recently announced contract manufacturing news... Read


Chromatide wins GRAND grant for enzyme-catalysis development
Chromatide has been awarded a grant to help it develop an enzyme immobilisation method using its unique polymer systems that should enable them to be used in flow-chemistry systems... Read

Weekly Comment

South Africa 'underutilised' for clinical trials

While India, the Asia-Pacific, Eastern Europe and Latin America are all gaining recognition as potential new hot spots, South Africa remains 'underutilised as a clinical trial destination,' according to a prominent industry figure. Read



Previous Headlines



Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, news has emerged involving ChemDiv, SRI International, ShangPharma, Ranbaxy and Xceleron... Read


Targeted Genetics restarts trial after death
The US Food and Drug Administration has allowed Targeted Genetics to restart testing its arthritis gene therapy after deciding the drug wasn't at fault when one person died in the original clinical trial... Read


Paediatric drugs and testing highlighted
The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego... Read


Exploring protein interactions in 'technicolour'
A triple-colour bioluminescent assay has been developed that promises to speed-up high content screening (HCS) analysis by enabling multiple-target monitoring... Read


Pharma should keep outsourcing in mind
The pharmaceutical industry is backward when it comes to outsourcing, industry experts said at the American Association of Pharmaceutical Scientists (AAPS) conference in San Diego last week... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation

DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com